MedPath

To study the roll of Rajanyadi Ksheerpaka Parisheka kriyakalp in treatment of patients with dryness of eyes as symptom in comparison with regularly used Carboxymethylcellulose Eye Drops.

Phase 2
Conditions
Health Condition 1: H048- Other disorders of lacrimal system
Registration Number
CTRI/2024/03/064542
Lead Sponsor
Dr Anjali Shelke
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient suffering from symptoms of Shushkakshipaka (Netrashushkata, Netra

Toda, Vilokane cha Avildarshanam, Gharsha, etc.)

2. Patients age group between 30-50 years irrespective of gender, economical status.

3. Patients with 5 mm- 15 mm on Schirmer’s I test.

Exclusion Criteria

1. Patients having any ocular infection.

2. Patients having any congenital eye anomaly.

3. Patients having any systemic disorder like diabetes mellitus, hypertension and

autoimmune disorders like Sjogren’s syndrome etc.

4. Patients having any corneal pathology.

5. Patients having congenital absence of meibomian glands and other lid disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rajanyadi Ksheerpaka Parisheka is significantly effective in the treatment of Shushkakshipaka (Dry Eye Syndrome) than Carboxymethylcellulose Eye DropsTimepoint: follow up on Day 0th, 3rd,7th,14th
Secondary Outcome Measures
NameTimeMethod
Rajanyadi Ksheerpaka Parisheka is not effective in the treatment of Shushkakshipaka (Dry Eye Syndrome) than Carboxymethylcellulose Eye DropsTimepoint: follow up on Day 0th, 3rd,7th,14th
© Copyright 2025. All Rights Reserved by MedPath